RIVN
Rivian Automotive, Inc.
RIVN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
SCI
Service Corporation International
SCI has a slight edge over RIVN overall, supported by lower modeled downside and stronger fundamentals.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SCI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
SCI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
SCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $60.18 | -20% |
| Forward | 18x | $74.97 | — |
| Current | 19x | $74.97 | — |
| Fair | 20x | $80.86 | +7.9% |
| Expensive | 22x | $88.36 | +18% |
Historical ranges are pointers, not guarantees.
SCI's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over SCI on the outlook, with more favorable revenue and profitability expectations.
SCI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect SCI's earnings to grow, with its revenue and profitability holding steady.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
SCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.22 | +4.8% |
| Q3 2026 | $4.03 | +9.2% |
| Q2 2026 | $3.83 | +4.4% |
| Q1 2026 | $3.79 | +4.7% |
| Q4 2025 | $3.80 | +7.6% |
| Q3 2025 | $3.69 | +7% |
| Q2 2025 | $3.67 | +6.7% |
| Q1 2025 | $3.62 | +3.7% |
| Q4 2024 | $3.53 | 0% |
SCI has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
SCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +4.6% |
| Q2 2026 | $1.1B | +3.6% |
| Q1 2026 | $1.1B | +2.1% |
| Q4 2025 | $1.1B | +1.7% |
| Q3 2025 | $1.1B | +4.4% |
| Q2 2025 | $1.1B | +3% |
| Q1 2025 | $1.1B | +2.8% |
| Q4 2024 | $1.1B | +3.5% |
SCI's revenue has grown year over year for 14 quarters in a row: $1.1B last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +1.4 points |
| Q2 2026 | 21% | -0.1 points |
| Q1 2026 | 22% | -1.2 points |
| Q4 2025 | 25% | +0.8 points |
| Q3 2025 | 21% | +0.4 points |
| Q2 2025 | 21% | -0.3 points |
| Q1 2025 | 23% | +1.2 points |
| Q4 2024 | 24% | +1.1 points |
SCI has the edge over RIVN on profitability, with a higher operating margin.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
SCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $197.4M | +31% |
| Q2 2026 | $142.9M | +71% |
| Q1 2026 | $253.9M | +9% |
| Q4 2025 | $87.2M | -43% |
| Q3 2025 | $150.7M | -7.5% |
| Q2 2025 | $83.4M | -17% |
| Q1 2025 | $233M | +66% |
| Q4 2024 | $151.8M | -17% |
SCI has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.1M shares |
| 1 year | -3% | -4.2M shares |
| 3 years | -9.9% | -15.1M shares |
| 5 years | -19% | -32.8M shares |
| Available history | -26% | -48.3M shares |
SCI has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $52.6M |
| Q2 2026 | $123.2M |
| Q1 2026 | $143.2M |
| Q4 2025 | $58.9M |
| Q3 2025 | $78.1M |
| Q2 2025 | $193.6M |
| Q1 2025 | $130.5M |
| Q4 2024 | $56.2M |
SCI spent $378M buying back its own shares over the past year, down 18% from the year before.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 4.0x | High |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.0x | Elevated |
SCI's net debt is about 4.0 years of its operating earnings (EBITDA), about the same as a year ago.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
SCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.2 | Neutral |
| Stochastic | 31.6 | Neutral |
SCI's weekly RSI is 43 (neutral) and its Stochastic is 32 (neutral).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
SCI PE vs Consumer Cyclical Sector
| Metric | SCI | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 3.2% above |
| PE % | 34 | 47 | 13 pts below |
SCI is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
SCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $77.7 | 3.5% below |
| 20 week MA | $80.2 | 6.5% below |
| 50 week MA | $79.7 | 5.9% below |
| 100 week MA | $79.5 | 5.7% below |
| 200 week MA | $74.6 | 0.5% above |
SCI has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.
SCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.1 | $48.7 | +5.6% |
| 2021 | $48.7 | $69.7 | +43% |
| 2022 | $69.7 | $70.2 | +0.8% |
| 2023 | $70.2 | $68.5 | -2.5% |
| 2024 | $68.5 | $80.8 | +18% |
| 2025 | $80.8 | $78.0 | -3.5% |
| 2026 YTD | $78.0 | $75.0 | -3.8% |
SCI has the edge over RIVN on returns for 2026, with the stronger performance.